Stocktoria
BridgeBio Pharma, Inc. BBIO
BridgeBio Pharma, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 9,949,219 | $741.0M | 5.11% |
| TWO SIGMA INVESTMENTS, LP | 4,745,285 | $353.4M | 2.44% |
| CITADEL ADVISORS LLC | 4,326,928 | $322.3M | 2.22% |
| BlackRock Finance, Inc. | 12,448,272 | $315.3M | 6.39% |
| D. E. Shaw & Co., Inc. | 3,663,907 | $272.9M | 1.88% |
| Point72 Asset Management, L.P. | 1,532,782 | $114.2M | 0.79% |
| RENAISSANCE TECHNOLOGIES LLC | 856,846 | $63.8M | 0.44% |
| MILLENNIUM MANAGEMENT LLC | 669,794 | $49.9M | 0.34% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.